SynthesisDer Internist2013
[J curve: when lowering blood pressure becomes a hazard?].
Synthesis in Der Internist, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Very low diastolic blood pressure is known to be associated with increased cardiovascular risks. The risk of low systolic pressure, however, is disputed. This survey analyses the bulk of recent studies on this topic. In hypertensive individuals without comorbidity, neither a systolic nor a diastolic J curve could ever be detected. In contrast, in patients with coronary heart disease, diabetes, chronic kidney disease, or left ventricular hypertrophy, most studies document diastolic pressure < 70 mmHg (range 60-80 mmHg) as well as systolic pressure < 120 mmHg (range 110-130 mmHg) to be associated with increased cardiovascular morbidity and mortality. Data on primary prevention of stroke are inconsistent. A large secondary prevention study found a higher risk of recurrent stroke in old patients (> 75 years) with an in-study systolic pressure < 120 mmHg. Because the majority of studies in hypertensive patients show the optimal blood pressure to be 130-140/70-80 mmHg with a trend to higher values in old patients, there is no need for further lowering. Further decline of hitherto controlled blood pressure should prompt screening for an occult disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.